PELLICULEX REVITALISANT / CONDITIONER DANDREX
Natural health product licensed in Canada
- Other names
- Revitalisant Antipelliculaire aux huiles essentielles / Conditioner Anti-dandruff with essential oils
- Licence holder
- Laboratoires Druide Inc./ Laboratoires Nelly De Vuyst/ Laboratoires Europelab
- NPN or DIN-HM
- 80053515
- Status
- Active licence
- Licence date
- 29 August 2014
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque | 1.8 % |
Non-medicinal ingredients
L-arginine, Glycérine, Huile de Fleur/Feuilles/Tige de Lavandula X Intermedia (Lavandin), Citrate de stéaryle, Beurre de Cacao, Huile essentielle de fruit de Citrus Aurantium Bergamia (Bergamote), Huile essentielle de Menthe Poivrée, Sorbitol Solution, Lauryl glucoside, Bentonite, Extrait de Rosmarinus Officinalis, Acide lévulinique, Glucoside de décyle, Propanediol, Gomme de xanthane, Jus en poudre de feuille d'Aloe Barbadensis, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Tout âge | Not specified | Not specified | Not specified |
Uses authorised in Canada
Pour soulager, prévenir et limiter la récurrence des pellicules ou des symptômes (démangeaison, irritation, rougeur, desquamation) associés aux pellicules.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80053515
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.